Genomic screening for infectious agents using nucleic acid amplification testing can be performed with several nucleic acid amplification techniques. Polymerase chain reaction, ligase chain reaction, nucleic acid sequence-based amplification, and transcription-mediated amplification are genomic amplification techniques that use different approaches to achieve the in vitro amplification of nucleic acids. Nucleic acid sequence-based amplification and transcription-mediated amplification are used to amplify RNA targets (eg, HCV and HIV), whereas polymerase chain reaction and ligase chain reaction need DNA or cDNA sequences as targets and therefore require a reverse transcription step for the amplification of RNA viruses.
Adroit Market Research study on the global market for nucleic acid amplification testing offers a holistic view of the industry from 2020 to 2028 as forecast period, including factors such as market drivers, limitations, opportunities, threats and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2020 and a projection from 2021 to 2028. The report covers the current status and potential characteristics of the market at both the global and the country level. Moreover, the report also assesses market competition with Porter's analysis of five strengths and places leading players on the basis of their product range, regional presence, strategic initiatives and overall sales. Prominent players in the global nucleic acid amplification testing market have been analyzed in depth.
All of these techniques directly detect the presence of infectious microorganisms in donor blood by amplifying the nucleic acid sequences specific to the microorganism. Use of these techniques provides a much higher level of sensitivity and specificity than routine testing methods currently provide. Despite the current diligent EIA screening of donor blood for the detection of antigens and antibodies, there still remains a residual risk of post transfusion infection from HIV or hepatitis viruses acquired from donors donating in the early window (or latent) period of infection. The power of nucleic acid amplification testing is its ability to detect the presence of infection by directly testing for viral genomic nucleic acids rather than by indirectly testing for the presence of antibodies.
The key players of global nucleic acid amplification testing market report include F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Beckman Coulter, Inc., Abbott Laboratories, Inc., Illumina, Inc., Siemens Healthineers, bioMérieux SA, Novartis AG, Bio-Rad Laboratories, Inc. among others.
Key Segments of the Global Nucleic Acid Amplification Testing Market
Technique Overview, 2018-2028 (USD Million)
- Target Amplification Systems
- Probe Amplification Systems
- Signal Amplification
Application Overview, 2018-2028 (USD Million)
- Infectious Diseases
- Personalized Medicine
- Genetic and Mitochondrial Disorders
Regional Overview, 2018-2028 (USD Million)
- Rest of Europe
- Rest of Asia-Pacific
Middle East and Africa